08th week of 2010 patent applcation highlights part 41 |
Patent application number | Title | Published |
20100047116 | Method Of Sterilizing - A bio-air sterilization system and method of use thereof is provided that can remove and render benign harmful contaminants and particulates, such as bacteria, viruses, and molds, from air within an enclosed area, as well as, in principle, from the exposed surfaces located within the enclosed area. In one aspect, the sterilization system includes a self contained, mobile sterilization unit that includes at least an ultraviolet array, an air flow control mechanism for diverting the air flow within the system through either a filter or through an ozone removal zone, an ozone generator, and a blower apparatus to pull the air through the system and out through ports, such as a nozzle system, to the surrounding environment. | 2010-02-25 |
20100047117 | PROCESS FOR AIR PURIFICATION AND AIR PURIFIER DEVICE FOR ITS IMPLEMENTATION - This invention relates to the purification of indoor air using a method that essentially comprises forcing the air to be processed to flow through an active medium exposed to a germicidal radiation in the presence of a photocatalytic material contained therein, with a destructive action on the microorganisms optionally present in the air and retained in the active medium such as reduced and/or weakened due to the impact on wall members provided therefore in the active medium. A first active medium includes a mass made in the form of a three-dimensional network of walls with photocatalytic surfaces and located in the immediate vicinity of a germicidal radiation source. A second active medium includes a liquid mass in which particles with a photocatalytic surface are dispersed and submitted to a germicidal radiation. The liquid mass is agitated by feeding air therein in order to generate a vortex. | 2010-02-25 |
20100047118 | METHOD FOR REDUCING ALLERGENS IN AN ENCLOSURE - Provided is a method for reducing the amounts of fungal spores and small airborne particles in an enclosure, where the enclosure has or is in communication with an air handling system. The method comprises the steps of applying vacuum suction to the air handling system and contacting the air handling system with a first antimicrobial agent; applying a cleansing agent to the carpets and upholstery in the enclosure; fogging the enclosure with a second antimicrobial agent; releasing ozone within the enclosure for a period of time and terminating the release of ozone to allow the ozone concentration to return to normal levels; placing a reservoir containing tea tree oil into the air handling system, and initiating operation of an air purifier air in the enclosure, wherein for a period of at least 90 days, the airborne particles in the enclosure are fewer than 1.0 million airborne particles per cubic meter of air; the airborne fungal spores in the enclosure an amount at least 1.1 times below the amount of airborne fungal spores in the air outside the enclosure before performing the method; and, the surface fungal spores in the enclosure are at least 3.0 times below the surface level of fungal spores in the enclosure before performing the method. | 2010-02-25 |
20100047119 | DEODORIZER/DISINFECTANT FLUID TREATMENT SYSTEM AND LINER FOR USE THEREWITH. - A system for treating and deodorizing objects such as clothing, bedding, or the like, comprising a bag for receiving said objects, and a system for dispersing a deodorizing treatment fluid such as ozone or the like therethrough. Another embodiment of the present invention contemplates a liner to contain and direct a treatment fluid into an absorbent such as pet litter or the like, to disinfect and renew. A complimentary system to the present invention teaches a deodorization, disinfectant, treatment bin for treating litter infused with animal waste, which treatment bin includes a treatment area utilizing ozone to contain and treat the contaminated litter, rendering same re-useable. The system of the present invention further contemplates an ozone generator having a timer circuit for providing a flow of ozone to the apparatus of the present invention, the ozone generator further contemplating as exemplary features a timer apparatus for providing optimal treatment, as well as a proximity sensor system for sensing the presence of an animal in the litter area, for controlling the ozone generator. | 2010-02-25 |
20100047120 | METHOD FOR STERILIZING PREFORMS AND INSTALLATION FOR PRODUCING STERILE BODIES FROM THESE PREFORMS - The invention relates to a sterilization method and to an installation ( | 2010-02-25 |
20100047121 | PROCESS AND APPARATUS FOR STERILIZING LIQUIDS FOR MEDICAL USE - The novel sterilization process disclosed herein still relies on the sterilization action resulting from exposure of the liquids and inner surfaces of the medical article to appropriate temperatures for well-determined times, but the sterilization temperature shall be attained through generation of heat in the article itself and not through heat transfer from outside to inside. This shall be obtained through the generation of a medium to high frequency electromagnetic field, whose characteristics are precisely determined to reach the desired temperature in as little time as possible and to maintain it for the time required for safe sterilization of the article. | 2010-02-25 |
20100047122 | SYSTEM AND METHOD FOR AUTOMATED STERILE SAMPLING OF FLUID FROM A VESSEL - A sampling system includes a steam source, a steam valve connected the steam source, a sampling valve connected to the fluid sample source, an isolation valve, a processing module, a drain valve, a drain, and a controller. The controller to passes cleaning fluid from the processing module through the isolation valve to the drain, passes steam through the steam valve, sampling valve, and isolation valve to the drain for a duration sufficient to sterilize the sampling valve, the isolation valve, and a fluid path therebetween, and passes fluid samples from the fluid sample source through the sampling valve and isolation valve to the processing module. The system and a method described delivers safer, more consistent sampling, while reducing the risk of contamination during extraction of a sample from a vessel and minimizing waste of the sample. | 2010-02-25 |
20100047123 | STERILIZATION CAPS AND SYSTEMS AND ASSOCIATED METHODS - One or more caps can be used to cover and sterilize one or more separated medical connectors. A pair of caps can be connected to each other and sealed when in a pre-use state. The paired caps can be unsealed so as to permit connection to the medical connectors. | 2010-02-25 |
20100047124 | Self decontaminating system and fabric - A self-decontaminating system for decontaminating a surface on demand is disclosed herein. The system contains an electrochemical cell and at least one portion of the surface forms a functional component of the cell. The system may include an electrocatalytic fabric which is flexible and resistant to tears and breaks, such that the fabric can be rolled up or pleated in order to provide a high surface area structure that can serve as an active filter. The fabric can function as a stand-alone system or a protective coating. Also disclosed are methods for fabricating, decontaminating, and regenerating the self-decontaminating fabric. | 2010-02-25 |
20100047125 | APPARATUS FOR THERMAL CONDITIONING A PRODUCT - An apparatus for providing a thermal treatment to a product, such as food, is described. One embodiment of the apparatus includes lime and water contained separately within a sealed reaction vessel. The reaction vessel includes a flexible wall portion that is adjacent to a perforator that can puncture a membrane separating the lime and water. In one embodiment, the perforator is separate from and fee-floating within the water. In another embodiment, the reaction vessel is substantially surrounded by the product. The reaction vessel is hermetically sealed against underpressure or overpressure, permitting use with pressurized food. The reaction vessel can be incorporated into a variety of containers and the reaction vessel and container can be sterilized for packaging food. | 2010-02-25 |
20100047126 | ANALYTE METER SLEEVES AND METHODS - In some aspects, an analyte meter sleeve is provided for storing an analyte meter (e.g., a blood glucose meter or insulin pump) and a lancet device. The sleeve includes a first sleeve member adapted to receive the analyte meter and a second member affixed to the sleeve and adapted to receive the lancet device. The first sleeve member may have a window adapted to allow viewing of a meter display. Numerous other aspects are provided. | 2010-02-25 |
20100047127 | Conditioning slurry samples for quantitative instrumental analysis - A method and system to consistently and automatically conditioning and delivering a solid-free liquid (filtrate) sample suitable for instrumental analysis is disclosed. A slurry, preferably a slurry produced by a sub-atmospheric pressure chlorate dioxide generating process, is fed through a filter to remove the solid phase and to provide the liquid phase on the downstream side of the filter, where the concentration of at least one dissolved component is determined. | 2010-02-25 |
20100047128 | LIQUID ASPIRATING APPARATUS AND SAMPLE ANALYZER - The present invention is to present a liquid aspirating apparatus comprising: a liquid aspirating nozzle; an aspirator for aspirating liquid through the liquid aspirating nozzle; a washing liquid discharging nozzle being arranged along a longitudinal direction of the liquid aspirating nozzle, wherein a discharge hole for discharging washing liquid is formed on the washing liquid discharging nozzle and the discharge hole faces a side surface of the liquid aspirating nozzle; and a washing liquid supplier for supplying the washing liquid to the side surface of the liquid aspirating nozzle through the discharge hole of the washing liquid discharging nozzle. | 2010-02-25 |
20100047129 | FECAL SAMPLING DEVICE AND METHOD - A device for testing a specimen comprising a first panel, a metering aperture structure having a plurality of metering apertures formed therein for receiving the specimen therethrough, a second panel opposite the first panel, a sheet disposed between the first and second panels, the sheet including a test area aligned with the plurality of metering apertures, a spacer element disposed between the first panel and the sheet, wherein the metering aperture structure is spaced away from the test area thereby improving readability of the testing. A method of manufacturing a specimen testing device is also disclosed. | 2010-02-25 |
20100047130 | Lab-On-Cd Systems With Magnetically Actuated Micro Check Valves And/Or Magnetic Immobilization - The present invention provides lab-on-CD (LoCD) systems for conducting chemical and biological reactions. One of the LoCD systems comprises a microfluidic CD with at least one magnetically actuated micro check valve, said microfluidic CD having at least one sample reservoir, at least one reaction chamber, and at least one microfluidic channel connecting the at least one sample reservoir and the at least one reaction chamber; wherein the at least one magnetically actuated micro check valve is positioned to control the microfluidic flow in the at least one microfluidic channel; and a supporting CD with at least one magnetic element for providing a magnetic force; thereby when the microfluidic CD and the supporting CD are assembled into the LoCD system, the at least one magnetic element can move the at least magnetically actuated micro check valve so as to control the microfluidic flow in the at least one microfluidic channel. | 2010-02-25 |
20100047131 | TESTING DEVICE - A testing device is provided which is able to distribute a liquid sample to a plurality of reaction sections by a simple operation without using a tip dispenser, and also achieves individually independent reaction systems without causing reaction sections to be in communication with each other due to a liquid sample. The testing device has a transparent molded body which includes: a storage chamber for injecting/holding a liquid sample; a reaction chamber for causing a reaction of the sample; a receiving chamber for sucking and receiving the sample, with the storage chamber and the reaction chamber being in communication with each other via a distributing flow path, and the reaction chamber and the receiving chamber being in communication with each other via a sucking flow path; and a liquid reservoir between the reaction chamber and the receiving chamber. | 2010-02-25 |
20100047132 | Micro Plate Treating Device and Micro Plate Treating Method - An object is to provide a micro plate treating device and micro plate treating method capable of handling a larger number of kinds of solution or suspensions or a larger volume of solutions or suspensions per work area by use of a normalized micro plate without enlarging the scale of the device. | 2010-02-25 |
20100047133 | Exhaust Gas Purifying Apparatus for Internal Combustion Engine - The present invention has an object to provide an exhaust gas purifying apparatus for an internal combustion engine capable of obtaining accurate temperature information relating to a catalyst placed in an exhaust passage of the internal combustion engine. The degree of influence emthc of a catalyst inlet gas temperature and catalyst rear end temperature ethuf[end] is calculated (Step | 2010-02-25 |
20100047134 | FLUIDIZED BED WASTEWATER TREATMENT APPARATUS - A fluidized bed reactor for removing phosphorus and nitrogen from wastewater has a column comprising a number of sections. The diameter of the column changes stepwise between the sections. A flow velocity in excess of 100 cm/min is maintained in a lowermost one of the sections and lower flow velocities are maintained in subsequent sections. A struvite supersaturation ratio is controlled in part by recycling wastewater from an outlet of the column. Struvite pellets are removed periodically from the bottom of the column. | 2010-02-25 |
20100047135 | PRESSURE VESSEL ARRANGEMENT COMPRISING AN EXTERNAL PRESSURE VESSEL AND AT LEAST ONE INSERT BASKET - A pressure vessel arrangement comprises an external pressure vessel and at least one insert basket in the pressure vessel for receiving a substance to be treated which is exposable to a pressure fluid which is feedable to the pressure vessel and the insert basket. There is provided a control device for the internal pressure prevailing in the insert basket, in particular in the form of a switchable pressure compensation line connecting the interior of the insert basket directly to the surroundings, i.e. not via the pressure vessel. | 2010-02-25 |
20100047136 | HIGH-PRESSURE FLUIDIZED BED REACTOR FOR PREPARING GRANULAR POLYCRYSTALLINE SILICON - The present invention relates to a high-pressure fluidized bed reactor for preparing granular polycrystalline silicon, comprising (a) a reactor tube, (b) a reactor shell encompassing the reactor tube, (c) an inner zone formed within the reactor tube, where a silicon particle bed is formed and silicon deposition occurs, and an outer zone formed in between the reactor shell and the reactor tube, which is maintained under the inert gas atmosphere, and (d) a controlling means to keep the difference between pressures in the inner zone and the outer zone being maintained within the range of 0 to 1 bar, thereby enabling to maintain physical stability of the reactor tube and efficiently prepare granular polycrystalline silicon even at relatively high reaction pressure. | 2010-02-25 |
20100047137 | UV ASSISTED POLYMER MODIFICATION AND IN SITU EXHAUST CLEANING - Methods and apparatus for the removal of exhaust gases are provided herein. In some embodiments, an exhaust apparatus may include a housing defining an inner volume; an inlet and an outlet formed in the housing to facilitate flow of an exhaust gas through the inner volume, wherein the inlet is configured to be coupled to a process chamber to receive an exhaust therefrom; and an ultraviolet light source to provide ultraviolet energy to the inner volume. The ultraviolet light source may provide sufficient energy to at least partially decompose the exhaust gases. In some embodiments, the ultraviolet light source may provide ultraviolet energy until the exhaust gas has cooled below a critical temperature. | 2010-02-25 |
20100047138 | REACTIVE OXYGEN SPECIES GENERATOR, WASHING DEVICE AND WASHING METHOD - The invention relates to a reactive oxygen species (ROS) generator ( | 2010-02-25 |
20100047139 | FUEL PROCESSOR FOR USE WITH PORTABLE CELLS - The invention relates to a fuel processor that produces hydrogen from a fuel. The fuel processor comprises a reformer and a heater. The reformer includes a catalyst that facilitates the production of hydrogen from the fuel; the heater provides heat to the reformer. Multipass reformer and heater chambers are described that reduce fuel processor size. Single layer fuel processors include reformer and heater chambers in a compact form factor that is well suited for portable applications. Some fuel processors described herein place an electrically resistive material in contact with a thermally conductive material to heat fuel entering the fuel processor. This is particularly useful during start-up of the fuel processor. Fuel processors described may also include features that facilitate assembly. | 2010-02-25 |
20100047140 | APPARATUS FOR PRODUCING LACTIC ACID - An apparatus for producing lactic acid according to the invention comprises a reactor carrying out: subjecting glycerin to a hydrothermal reaction under an alkaline condition, supplying an alkaline solution comprising glycerin; and continuously producing lactic acid, wherein glycerin is subjected to a hydrothermal reaction under an alkaline condition at a temperature in the range of 150 to 400° C. and under pressure equal to or more than the saturated vapor pressure at the temperature. The glycerin produced from plant fats, animal fats or the like or pure product synthesized chemically or a discharge containing glycerin generated at the production of diesel fuel oil from fats, in which the fats are subjected to a transesterification with alcohol in the presence of an alkali catalyst in order to obtain fatty acid ester is preferably used as a starting material. | 2010-02-25 |
20100047141 | Method and Apparatus for the Recovery of Molybdenum from Spent Catalysts - This invention relates to an apparatus and process that utilizes high-temperature oxidation and sublimation techniques for the recovery of molybdenum from spent catalysts or other feedstocks that contain molybdenum. A preferred embodiment uses a counter-rotating vortex reactor and a cyclonic entrained-flow reactor to rapidly heat and oxidize the spent catalyst feedstock, such as carbon, sulfur, and molybdenum compounds, at temperatures in the range of about 2100° F. to 2900° F., resulting in a gas-solid stream containing molybdenum trioxide vapor. A high-temperature cyclone separator is utilized to separate the residue from this stream before this stream is rapidly quenched to a temperature sufficient to effect the condensation of solid molybdenum trioxide without condensing arsenic or phosphoric oxides. The condensed molybdenum trioxide material is separated from this stream by passing through a high-temperature filtration system. The remaining gaseous stream is then ducted to suitable unit operations for possible further material reclamation and entailed pollution control prior to its final discharge to the atmosphere. | 2010-02-25 |
20100047142 | FILTER MEDIA INCLUDING FILTERING AGENT EFFECTIVE FOR REMOVAL OF CYANO-CONTAINING CONTAMINANTS HAVING IMPROVED COMPATIBILITY WITH AMINE SENSITIVE IMPREGNANTS AND AMINE SENSITIVE SUBSTRATES - Filter media containing an impregnant obtained by pre-reacting an amine functional material with a transition metal to form an amine-metal coordination complex. The complexed amine is much more compatible with amine sensitive co-impregnants or amine sensitive substrates. Additionally, even though the amine is complexed, the impregnant retains high activity for the removal of cyano-containing vapors and other contaminants for which amines have a filtering efficacy. Advantageously, therefore, the filter media may be used to remove cyano-containing vapors or other amine-targeted contaminants from air and other harmful gases in the presence of metal-based catalysts (such as those catalysts comprising platinum, gold or other active transition metals) without the undesirable effect of unduly inhibiting or poisoning the metal-based catalysts. The amine-containing coordination complex is also more compatible with substrates having electret characteristics as compared to otherwise identical amine material that is not complexed. | 2010-02-25 |
20100047143 | OXIDATION CATALYST - A catalyst for selective oxidation of hydrocarbons relative to carbon monoxide includes a mixed oxide based on the compound Ce | 2010-02-25 |
20100047144 | Method for the Selective Catalytic Reduction of Nitrogen Oxides in Exhaust Gases of Vehicles - The invention relates to a method for the selective catalytic reduction of nitrogen oxides using ammonia in exhaust gases of vehicles, whereby solutions of guanidine salts with an ammonia forming potential of between 40 and 850 g/kg, optionally in combination with urea and/or ammonia and/or ammonium salts, are catalytically decomposed in the presence of catalytically active, non-oxidation-active coatings of oxides selected from the group containing titanium dioxide, aluminum oxide, silicon dioxide or the mixtures thereof, and hydrothermally stable zeolites which are fully or partially metal-exchanged. The guanidine salts according to the invention enable a reduction of the nitrogen oxides by approximately 90%. Furthermore, said guanidine salts can enable an increase in the ammonia forming potential from 0.2 kg, corresponding to prior art, up to 0.4 kg ammonia per litre of guanidine salt, along with freezing resistance (freezing point below −25° C.). The risk of corrosion of the guanidine salt solutions used according to the invention is also significantly reduced compared to that of solutions containing ammonium formiate. | 2010-02-25 |
20100047145 | Systems And Methods For Removing Contaminants From Fluid Streams - A system for contaminant removal from a fluid stream comprises a plurality of flow through reactors arranged in stages that are spaced apart from one another, each reactor comprising at least one flow-through monolith configured to react with at least one contaminant in a fluid stream, and a flow control system configured to selectively control through which of the plurality of flow-through reactor stages a fluid stream containing at least one contaminant may pass. | 2010-02-25 |
20100047146 | SORBENTS FOR THE OXIDATION AND REMOVAL OF MERCURY - A promoted activated carbon sorbent is described that is highly effective for the removal of mercury from flue gas streams. The sorbent comprises a new modified carbon form containing reactive forms of halogen and halides. Optional components may be added to increase reactivity and mercury capacity. These may be added directly with the sorbent, or to the flue gas to enhance sorbent performance and/or mercury capture. Mercury removal efficiencies obtained exceed conventional methods. The sorbent can be regenerated and reused. Sorbent treatment and preparation methods are also described. New methods for in-flight preparation, introduction, and control of the active sorbent into the mercury contaminated gas stream are described. | 2010-02-25 |
20100047147 | CIRCULATING FLUIDIZED BED POWER PLANT HAVING INTEGRATED SULFUR DIOXIDE SCRUBBER SYSTEM WITH LIME FEED - A circulating fluidized bed power plant | 2010-02-25 |
20100047148 | Skull reactor - A method for producing silicon or a reactive metal is disclosed herein that includes:
| 2010-02-25 |
20100047149 | METHODS FOR PREPARING COMPOSITIONS COMPRISING AMMONIUM NITRATE DOUBLE SALTS - Methods for the production of ammonium sulfate nitrate include (a) providing at a temperature of less than about 175° C. a melt including ammonium nitrate, ammonium sulfate, and water and the water content is greater than about 2 wt % based on the total weight of ammonium nitrate, ammonium sulfate and water in the melt, and (b) solidifying from the melt 1:2 ANS double salt by cooling at least a portion of the melt at a rate of less than about 100° C./min. | 2010-02-25 |
20100047150 | Method And Apparatus For Producing Carbon Monoxide By Cryogenic Distillation - A method and an apparatus for producing carbon dioxide by cryogenic distillation is provided. | 2010-02-25 |
20100047151 | ELONGATED NANO STRUCTURES - There are provided techniques for preparing an elongated nano structure. In one embodiment, an insulator may be deposited on a substrate. The insulator and the substrate may then be patterned to define one or more grooves. After a suspension, emulsion, solution or liquid mixture of nano materials is supplied on the insulator and the groove(s), a gas Jet may be applied on the insulator and cause the nano-materials to be trapped in the groove(s). Thereafter, the insulator may be removed. | 2010-02-25 |
20100047152 | GROWTH OF CARBON NANOTUBES USING METAL-FREE NANOPARTICLES - The present invention provides a method for forming at least one carbon nanotube ( | 2010-02-25 |
20100047153 | METHOD OF MANUFACTURING CARBON FIBRES - The present invention relates to a method of manufacturing carbon fibres from raw materials of renewable origin, comprising:
| 2010-02-25 |
20100047154 | METHOD FOR PREPARING GRAPHENE RIBBONS - Disclosed is a method for fabricating graphene ribbons, comprising: preparing a graphitic material comprising stacked graphene helices; and cutting the graphitic material in a short form by applying energy to the graphitic material; and simultaneously or afterward, decomposing the graphitic material into short graphene ribbons. This method provides a mass production route to graphene ribbons. | 2010-02-25 |
20100047155 | PROCESSES FOR CONJOINTLY PRODUCING BROMINE AND CALCIUM CHLORIDE - Processes are provided for conjointly producing Br2 and a concentrated aqueous solution containing at least about 5 wt % CaCI2, based on the weight of the concentrated aqueous solution, from an aqueous HBr rich stream and, optionally, a feed brine dilute in CaCI2. Such processes can comprise feeding the aqueous HBr-rich stream and the feed brine to a tower, oxidizing bromide moieties within the tower with Cl2 to produce Br2, recovering Br2 from the tower, removing a bromide-depleted bottoms from the tower, such bottoms containing HCI, adding a Ca++ source to the bromide-depleted bottoms to convert substantially all of the HCI in the bottoms to CaCI2, and, as necessary, removing water from the treated bottoms to produce the concentrated aqueous solution. | 2010-02-25 |
20100047156 | MULTIPLE STAGE REVERSE OSMOSIS METHOD FOR REMOVING BORON FROM A SALINATED FLUID - The presently described subject matter provides a method for reducing boron concentration in a process of desalination of high salinity liquid including passing the high salinity liquid through a first pass reverse osmosis (RO) device to produce a first pass permeate, where at least part of the first pass permeate is treated with a scale inhibitor to obtain a modified first pass permeate being fed into at least one additional RO device to produce at least an additional pass permeate, where the at least one additional pass permeate includes a lower boron concentration than that in the high salinity liquid. | 2010-02-25 |
20100047157 | PROCESS FOR PREPARATION OF ALUMINA PRECURSOR POWDER AND PROCESS FOR PREPARATION OF ALUMINA POWDER - There is provided a process for the preparation of a alumina precursor powder from aluminum hydroxide powder obtained by hydrolysis of aluminum alkoxide which precursor enables to provide alumina powder with a high volumetric efficiency. | 2010-02-25 |
20100047158 | METHOD AND REACTOR FOR PRODUCTION OF HYDROGEN - A method for production of hydrogen including reforming of a carbon comprising fuel is provided together with production plants adapted for obtaining hydrogen at lower temperatures and/or higher pressures and obtaining a CO | 2010-02-25 |
20100047159 | METHOD FOR RELEASING HYDROGEN FROM AMMONIA BORANE - A method of releasing hydrogen from ammonia borane is disclosed. The method comprises heating an aqueous ammonia borane solution to between about 80-135° C. at between about 14.7 and 200 pounds per square inch absolute (psia) to release hydrogen by hydrothermolysis. | 2010-02-25 |
20100047160 | SYSTEMS AND PROCESSES FOR PRODUCING ULTRAPURE, HIGH PRESSURE HYDROGEN - In various implementations, feed streams that include methane are reacted to produce synthesis gas. The synthesis gas may be further processed to produce ultrapure, high-pressure hydrogen streams. | 2010-02-25 |
20100047161 | FORMULATION AND METHOD FOR IMPROVED ION EXCHANGE IN ZEOLITES AND RELATED ALUMINOSILICATES USING POLYMER SOLUTIONS - Among other things, this disclosure provides a method for exchanging cations in an aluminosilicate. The method includes combining, in an exchange solvent and under ion exchange conditions, an ion-exchangeable aluminosilicate having a first cation associated therewith as a counter ion and a second cation source, to provide a mixture that includes the ion-exchanged aluminosilicate which includes the second cation associated therewith as a counter ion. Suitable exchange solvents include polyalkylene oxide glycols, polyalkylene oxide glycol monoethers, polyalkylene oxide glycol diethers, or any combination thereof. | 2010-02-25 |
20100047162 | METHODS OF PROCESSING MULTI-PHASIC DISPERSONS - A method for processing multi-phasic dispersions is provided. The method comprises providing a multi-phasic dispersion including dispersed and continuous phases, providing a non-solvent, combining the multi-phasic dispersion and the non-solvent, and selectively effecting migration of the dispersed phase into or through the non-solvent such that the microparticles are separated from the dispersion. | 2010-02-25 |
20100047163 | Synthetic LDL as Targeted Drug Delivery Vehicle - The present invention provides a synthetic LDL nanoparticle comprising a lipid moiety and a synthetic chimeric peptide so s to be capable of binding the LDL receptor. The synthetic LDL nanoparticle of the present invention is capable of c incorporating and targeting therapeutics for diseases associated with the expression of the LDL receptor. The invention further provides methods of using such synthetic LDL nanoparticles. | 2010-02-25 |
20100047164 | Anti-Tumor Antibodies - Chondroition sulfate proteoglycans represent excellent targets for anti-tumor immunotherapy. Antibodies which target such proteoglycans can be used alone, in combinations, armed with a cytotoxic payload or unarmed. Combinations of such antibodies can target different epitopes of the proteoglycans. Internalization of the antibodies can increase the toxicity of the payloads. Single chain variable regions are especially advantageous for such anti-tumor immunotherapy. | 2010-02-25 |
20100047165 | METHOD FOR DIAGNOSIS OF CHRONIC ALLOGRAFT REJECTION - The present invention provides a method for the diagnosis of chronic rejection in allografts. The method comprises identification of tertiary lymphoid organs (TLO) in the transplanted organs as a marker of chronic rejection by immunohistochemical detection for the presence of specific TLO antigens in biopsy samples or by radiographic imaging of radiolabeled antibodies to specific TLO antigens. In one embodiment, the presence of TLO is detected by the intravenous administration of a radiolabeled antibody to PNAd followed by radiographic imaging to determine the presence or absence of PNAd in the transplanted organ. The presence of PNAd in the transplanted organ is taken as an indication of chronic rejection. | 2010-02-25 |
20100047166 | ANTIBODIES AND RELATED MOLECULES THAT BIND TO 58P1D12 PROTEINS - Antibodies and molecules derived therefrom that bind to 58P1D12 protein and variants thereof, are described wherein 58P1D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 58P1D12 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 58P1D12 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 58P1D12 can be used in active or passive immunization. | 2010-02-25 |
20100047167 | COMBINATION THERAPY IN THE TREATMENT OF CANCER - Disclosed herein is a method of treating a tumor by administering to the subject a treatment effective amount of a therapeutic antibody and an alkylating agent. | 2010-02-25 |
20100047168 | Soluble Zcytor 11 Cytokine Receptors - Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for soluble zcytor11 receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides and antibodies can also be used to block TIF activity in vitro and in vivo, and may be used in conjunction with TIF and other cytokines to selectively stimulate the immune system. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto. | 2010-02-25 |
20100047169 | NK Cell Receptor Conjugates for Treating Malignancies - The present invention relates generally to compositions useful in therapies involving the selective destruction of tumor cells in vivo. In particular, this invention relates to a conjugate which comprises a target recognition segment and an active cytotoxic segment. The target recognition segment comprises a receptor specific to NK cells, wherein the receptor binds to a cellular ligand expressed on the surface of a tumor cell, and the active segment comprises an agent capable of exerting a cytotoxic effect on the tumor cell. The target recognition segment derived form the natural killer receptor NKp30 has been found to be particularly effective in vivo. | 2010-02-25 |
20100047170 | Peptide Prodrugs - Provided herein are a novel class of oligopeptides and prodrugs that include amino acid sequences containing cleavage sites for fibroblast activation protein (FAP). Also provided herein are methods of treating FAP related disorders, including cancer. | 2010-02-25 |
20100047171 | Fusion Proteins That Contain Natural Junctions - A method for preparing recombinant fusion proteins that comprise at least one natural junction is described. Fusion proteins that contain at least one natural junction have reduced potential for immunogenicity, improved stability, reduced tendency to aggregate, improved expression and/or improved production yields relative to conventional fusion proteins. Novel fusion proteins that comprise at least one natural junction, compositions comprising the fusion proteins and methods of using the proteins are also disclosed. | 2010-02-25 |
20100047172 | Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics - Provided herein are imaging methods for detecting, diagnosing and imaging pathogenic bacteria or a pathophysiological condition associated therewith using fluorescent, luminescent or colorimetric detection agents, e.g., fluorogenic substrates for bacterial enzymes, caged luciferins and fluorescent proteins, luciferases and enzymes expressed by recombinant bacteria. Signals emitted by the fluorescent, luminescent or colorimetric detection agents in the presence of the bacteria are compared to controls to detect and locate the pathogenic bacteria. Also provided is a method for screening therapeutic agents to treat the pathophysiological conditions by measuring fluorescence or luminescence emitted from the detection agents in the presence and absence of the potential therapeutic agent. In addition, a method for detecting a pathogenic bacteria via PET or SPECT imaging using a positron-emitting or gamma-emitting substrate for a beta-lactamase or other enzyme or protein of the pathogenic bacteria. Further provided are the fluorogenic substrates CNIR-7 or CNIR7-TAT or the radiolabeled substrates. | 2010-02-25 |
20100047173 | Methods for Using Optical Agents - In certain embodiments, the present invention is directed to novel processes for using hepatobiliary cleared optical agents to detect one or more tissues of the biliary tract of a surgical patient. In certain embodiments, the invention is directed to kits that include one or more optical agents and instructions for using the agent(s), for example, in a process of the invention. | 2010-02-25 |
20100047174 | AAV CAPSID LIBRARY AND AAV CAPSID PROTEINS - Recombinant adeno-associated viral (AAV) capsid proteins are provided. Methods for generating the recombinant adeno-associated viral capsid proteins and a library from which the capsids are selected are also provided. | 2010-02-25 |
20100047175 | Sincalide Formulations - The invention features sincalide formulations that include an effective amount of sincalide, a bulking agent/tonicity adjuster, a stabilizer, a surfactant, a chelator, and a buffer. The invention also features kits and methods for preparing improved sincalide formulations as well as methods for treating, preventing, and diagnosing gall bladder-related disorders using sincalide formulations. | 2010-02-25 |
20100047176 | Method and Kit for Testing Stress Effects in Living Organisms - The present invention concerns a method of testing whether a living organism has been exposed to stress, such as pesticide exposure, e.g., whether weed crops have been exposed to herbicide. Based on non-separated compounds obtained from an organism, e.g., an extract from a plant, a color development is generated. The color or shade developed is dependent on the compounds of the organism. By comparing the color or shade of the extract obtained from an organism with a standard color scale developed with respect to the same organism, it is possible to determine the final effect of the stress upon the growth of the plant. The invention also concerns a method of providing a standard color scale for material from a living organism that has been exposed to stress, e.g., a pesticide. As assay kit for the determination of the final effect of the stress upon the growth of the plant is also described. The present invention may be used by farmers or advisors to predict the final effect of herbicide treatment of plants before visual signs appear on the plants. | 2010-02-25 |
20100047177 | METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES - Methods of treating or preventing axonal degradation in neuropathic diseases and neurological disorders in mammals are disclosed. The methods can comprise administering to the mammal an effective amount of an agent that acts at least in part by increasing sirtuinAMPK activity, LKB 1 activity and/or CaMKKβ activity in diseased and/or injured neurons. The methods can also comprise administering to the mammal an effective amount of an agent that acts by increasing NAD activity in diseased and/or injured neurons, alone or in combination with agents that act by other mechanisms. Also disclosed are methods of screening agents for treating a neuropathies and recombinant vectors for treating or preventing such neuropathies. | 2010-02-25 |
20100047178 | PERYLENEQUINONE DERIVATIVES AND USES THEREOF - The present invention relates to compounds which are perylenequinone derivatives, their stereoisomers and atropisomers. These compounds can be particularly useful as photosensitizers or sononsensitizers in photodynamic or sonodynamic therapy. The invention also relates to various methods for using these compounds in photodynamic and/or sonodynamic therapy. The compounds also are useful as therapeutic agents for treating various hyperproliferative disorders. | 2010-02-25 |
20100047179 | TARGETED SPLIT BIOMOLECULAR CONJUGATES FOR THE TREATMENT OF DISEASES, MALIGNANCIES AND DISORDERS, AND METHODS OF THEIR PRODUCTION - The present invention is directed to compositions and methods for the production of split-biomolecular conjugates for the directed targeting of nucleic acids and polypeptides. More preferably, the compositions and methods allow for the use of the split biomolecular conjugates for the treatment of diseases, malignancies, disorders and screening. In some embodiments, the split biomolecular conjugates comprise split effector protein fragments conjugated to a probe, and interaction of both probes with a target nucleic acid or target polypeptide, such as a pathogenic nucleic acid sequence or pathogenic protein, brings a the split-effector fragments together to facilitate the reassembly of the effector molecule. Depending on the effector molecule, the protein complementation results in a cellular effect, in particular for the treatment of diseases, malignancies and disorders. | 2010-02-25 |
20100047180 | Iron/Iron Oxide Nanoparticle and Use Thereof - The present invention is a nanoparticle composition composed of an iron core with an iron oxide shell which is optionally coated with a micro-emulsion. The disclosed nanoparticle compositions are disclosed for use in hyperthermia treatment and imaging of cancer. | 2010-02-25 |
20100047181 | MIXTURE OF A VANILLOID RECEPTOR AGONIST AND A SUBSTANCE INHIBITING NERVE REGENERATION, USE THEREOF FOR PRODUCING A PAINKILLER, AND METHOD FOR APPLYING SAID PAINKILLER - The following abstract will replace all prior versions of the abstract in the application:
| 2010-02-25 |
20100047182 | IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the skin test, and predicting a treatment outcome. Methods of detecting defects in monocyte or T lymphocyte function, including the steps of administering an effective amount of an NCM or T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the skin test, and detecting at least one defect in monocyte or T lymphocyte function. A mechanism for indicating a functioning efferent or afferent limb of an immune system, including a diagnostic skin test including an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. | 2010-02-25 |
20100047183 | PESTICIDAL AEROSOL COMPOSITION - A pesticidal aerosol composition, containing 3-phenoxybenzyl ester compound represented by Formula (I): | 2010-02-25 |
20100047184 | PHARMACEUTICAL COMPOSITIONS CONTAINING AN EFFERVESCENT ACID-BASE COUPLE - A pharmaceutical composition in the form of effervescent tablets comprising an active ingredient and an effervescent blend, comprising an acidic component and sodium glycine carbonate as alkaline components. Preferred acid components are fumaric acid, maleic acid, and their salts. Tablets are prepared in normal thermohygrometric conditions and with standard tabletting equipment. A pre-granulation process is also disclosed. | 2010-02-25 |
20100047185 | ACTVIE SUBSTANCE COMBINATION - The present invention refers to a combination of at least 2 UV-absorbing active substances (A) and (B), wherein the UV-absorbing active substance (A) is at least one heptaazaphenalene compound of the general formula (I), which is defined in the description and the UV-ab-sorbing active substance (B) is at least one compound which has its ab-sorption maximum λ | 2010-02-25 |
20100047186 | Peptides and Their Use - The invention relates to peptides, and peptide variants thereof, in which substantially all of the amino acids in the amino sequence of said peptide are the same, for use as antibacterial agents. | 2010-02-25 |
20100047187 | METHODS OF TREATING PARKINSON'S DISEASE USING HALOGENATED VOLATILE COMPOUNDS - The present invention provides methods of using halogenated volatile compounds, e.g., halogenated ether, for treating a neurological disorder, e.g., Parkinson's disease. | 2010-02-25 |
20100047188 | MODULATION OF TOLL-LIKE RECEPTOR 8 EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES - Antisense oligonucleotide compounds, compositions and methods are provided for down regulating the expression of TLR8. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding TLR8. The compositions may also comprise antisense oligonucleotides targeted to nucleic acids encoding TLR8 in combination with other therapeutic and/or prophylactic compounds and/or compositions. Methods of using these compounds and compositions for down-regulating TLR8 expression and for prevention or treatment of diseases wherein modulation of TLR8 expression would be beneficial are provided. | 2010-02-25 |
20100047189 | AZEOTROPE-LIKE COMPOSITIONS OF 1,1,1,2-TETRAFLUOROPROPENE AND 1,1,1,2-TETRAFLUOROETHANE - Provided are azeotrope-like compositions consisting essentially of 1,1,1,2-tetrafluoropropene and 1,1,1,2-tetrafluoroethane and uses thereof, including use in refrigerant compositions, refrigeration systems, blowing agent compositions, and aerosol propellants. | 2010-02-25 |
20100047190 | USES AND METHODS FOR PREVENTING AND/OR TREATING CARIES CAUSED BY MUTANTS STREPTOCOCCI - The present invention relates to the use of a microorganism belonging to the group of lactic acid bacteria or a mutant or derivative thereof, characterized in that it is capable of specifically binding to a bacterium belonging to the group of mutans Streptococci, wherein the specific binding is (i) resistant to heat treatment; and/or (ii) resistant to protease treatment; and/or (iii) calcium-dependent; and/or (iv) formed within a pH range between 4.5 and 8.5; and/or (v) formed in the presence of saliva, for the preparation of an anticariogenic composition for the treatment or prevention of caries caused by mutans Streptococci other than | 2010-02-25 |
20100047191 | NOVEL USE - The use of an oral care composition comprising particulate zinc oxide (suitably in nanoparticulate form) optionally in the presence of a source of fluoride ions is described for combating dental erosion and/or tooth wear. Such compositions are also of use in combating dental caries. | 2010-02-25 |
20100047192 | Novel tyrosinase-specific anti-gene oligonucleotides as depigmenting agents - The present invention relates to an anti-gene oligonucleotide which hybridizes specifically with the gene encoding human tyrosinase by Hoogsteen pairing between the complementary bases, said oligonucleotide forming a triple helix structure with the human tyrosinase gene. The invention also relates to the use of said oligonucleotide as a skin-depigmenting or skin-bleaching agent in a cosmetic composition or in a dermatological composition. | 2010-02-25 |
20100047193 | FORMULATIONS INCLUDING SELF TANNING, SUN PROTECTION, AND SHAVING COMPOSITIONS - Formulations and methods are described. One embodiment relates to a self tanning formulation including a skin coloring active that stains the skin by reaction therewith. The self tanning formulation also includes a component comprising polyhydroxystearic acid and isononyl isononanoate and ethylhexyl isononanoate and sodium cocamidopropyl PG-dimonium chloride phosphate and methyl perfluorobutyl ether and methyl perfluoroisobutyl ether. The formulation also includes a surfactant and a solvent. Other embodiments relate to sun protection compositions and shaving compositions. Other embodiments are described and claimed. | 2010-02-25 |
20100047194 | Structurants for Oil Phases - Polyester oil structurants are obtainable by the reaction of a dimer based dicarboxylic acid, a polyol and a C | 2010-02-25 |
20100047195 | LIP BALM AND METHOD OF TREATING LIP CONDITIONS - A pharmaceutical composition for treating a lip condition. The pharmaceutical composition includes a therapeutically effective amount of a corticosteroid, or a physiologically acceptable salt of the corticosteroid, and a physiologically acceptable carrier In the composition, the corticosteroid does not include hydrocortisone. Also provided is a method of using the composition to treat a lip condition such as inflammation or infection. | 2010-02-25 |
20100047196 | NOVEL MICROSTRUCTURAL PROTEIN PREPARATIONS CONTAINING ADSORBED BIOLOGICALLY ACTIVE SUBSTANCES AND THEIR APPLICATION IN MEDICINE AND COSMETICS - Protein preparations containing biologically active compounds and the application of the protein preparations obtained, particularly as a component of medicinal and cosmetic preparations as protective substances or in the regeneration of cells and tissues of the human organism, and which can comprise a component of culture media for dermal or hepatic tissues, or for stem cells destined for use in the regeneration of cells and tissues in the human organism. | 2010-02-25 |
20100047197 | COSMETIC FORMULATION CONTANING GLUCOSYL GLYCERIDES AND UREA - Cosmetic preparation containing a combination of a) urea and b) one or more glucosyl glycerides. | 2010-02-25 |
20100047198 | Textile Scenting - A perfume-containing PIT emulsion which is suited to contribute to an excellent and long-lasting scenting of textiles during the use of a dryer. The PIT emulsion is simple for the user to handle and allows the user to better control the user's individual scent experience during the handling of textiles. The PIT emulsions can also be used for aroma therapy purposes and for the scenting of rooms. In addition, a kit made of detergents and the perfume-containing PIT emulsion, which enables the user to obtain optimal laundry scenting results. | 2010-02-25 |
20100047199 | THIN ALUMINUM PIGMENTS HAVING A NARROW THICKNESS DISTRIBUTION, METHOD FOR PRODUCING SAME, AND USE OF ALUMINUM PIGMENTS - The invention relates to aluminum pigments which are at least partially coated with lubricant, wherein the aluminum pigments have a relative breadth of thickness distribution Δh of from 30% to less than 70%, as determined by a scanning electron microscope thickness count and as calculated on the basis of the corresponding cumulative breakthrough curve of the relative frequencies of occurrence, according to the formula Δh=100×(h | 2010-02-25 |
20100047200 | Cosmetic product comprising two separte compositions, one of which comprises a crosslinked polyrotaxane - The invention relates to a cosmetic product comprising a first composition and a second composition, the first composition being anhydrous and comprising a crosslinked polyrotaxane and a second composition comprising a physiologically acceptable solvent capable of being absorbed by the said crosslinked polyrotaxane. The invention also relates to a make-up process and to a make-up kit. The latter is in particular a lipstick, a mascara or a foundation. | 2010-02-25 |
20100047201 | UNSATURATED FATTY SUBSTANCES FOR PROTECTING THE COLOR OF ARTIFICIALLY DYED KERATIN FIBERS WITH RESPECT TO WASHING; AND DYEING PROCESSES - Disclosed herein is a process involving the use of at least one unsaturated fatty substance of formula (I) as defined herein as an agent for protecting color with respect to the washing of artificially dyed keratin fibers such as artificially dyed hair. Also disclosed herein is a process for protecting the color of artificially dyed keratin fibers with respect to washing, comprising applying to the fibers, before or after dyeing, at least one composition comprising, in a cosmetically acceptable medium, at least one unsaturated fatty substance of formula (I). Further disclosed herein is a process for dyeing keratin fibers, comprising applying to the keratin fibers a direct or oxidation dye composition (A) for a time that is sufficient to develop the color, and following or preceding this application, applying a composition (B) comprising, in a cosmetically acceptable medium, at least one unsaturated fatty substance of formula (I). | 2010-02-25 |
20100047202 | Hair-Conditioning Agents Containing Selected Cationic Polymers and Water-Soluble Silicones - Cosmetic preparations, especially compositions that condition keratin fibers, which comprise at least two different cationic polymers and a water-soluble silicone. Said compositions are especially used to make the hair easy to comb and at the same time add volume to the hair. The compositions are preferably sprayed onto wet or dry keratin fibers, the composition preferably remaining on the keratin fibers until the next wash. | 2010-02-25 |
20100047203 | Use of Block Copolymers Based on Vinyllactams and Vinyl Acetate as Solubilizers - Use of polyvinyllactam-polyvinyl acetate block copolymers as solubilizers for active ingredients that are sparingly soluble in water. | 2010-02-25 |
20100047204 | USE OF ORGANIC COMPOUNDS - This invention relates to the use of compounds that disrupt IL-I receptor interaction for the treatment and/or prevention of ophthalmic diseases or disorders in mammals, particularly humans. | 2010-02-25 |
20100047205 | VACCINE IMMUNOTHERAPY - The present invention provides compositions and methods of immunotherapy to treat cancer or other antigen-producing diseases or lesions. According to one embodiment of the invention, a composition is provided for eliciting an immune response to at (east one antigen in a patient having an antigen-producing disease or lesion, the composition comprising an effective amount of a cytokine mixture, preferably comprising IL-1, IL-2, IL-6, IL-8, IFN-γ (gamma) and TNF-α (alpha). The cytokine mixture acts as an adjuvant with the antigen associated with the antigen-producing disease or lesion to enhance the immune response of the patient to the antigen. Methods are therefore also provided for eliciting an immune response to at least one antigen in a patient having an antigen-producing disease or lesion utilizing the cytokine mixture of the invention. The compositions and methods are useful in the treatment of antigen-producing diseases such as cancer, infectious diseases or persistent lesions. | 2010-02-25 |
20100047206 | POWDERY COMPOSITION FOR NASAL ADMINISTRATION - A powdery composition for nasal administration, where (1) the composition contains (i) a drug, (ii) a water-absorbing and gel-forming base material such as hydroxypropyl cellulose or hydroxypropylmethyl cellulose and (iii) a water-absorbing and water-insoluble base material such as crystalline cellulose or α-cellulose, (2) wherein the amount of the water-absorbing and gel-forming base material is about 5-40 wt % based on the total of the water-absorbing and gel-forming base material and the water-absorbing and water-insoluble base material, and (3) wherein the drug is unevenly dispersed more on/in the water-absorbing and water-insoluble base material than on/in the water-absorbing and gel-forming base material. | 2010-02-25 |
20100047207 | Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor Antibodies - The present invention describes specific therapeutic compositions, which increase the efficacy of the therapeutic treatment using monoclonal antibodies against the Epidermal Growth Factor Receptor (EGFR) in a combination with type I IFNs. | 2010-02-25 |
20100047208 | Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof - The present invention relates to gene therapy for tumors, specifically, it relates to the construction of oncolytic adenovirus recombinant, which specifically expresses immune modulatory factor GM-CSF in tumor cells and uses thereof. | 2010-02-25 |
20100047209 | Probiotic composition suitable for animals - The invention provides a probiotic composition to alleviate | 2010-02-25 |
20100047210 | Systems and Methods for Positioning of Needles and Other Devices Within Body Tissue - Systems and methods for delivering a substance (e.g., a therapeutic or diagnostic substance, drug, biologic, cells, etc.) or device (e.g., implantable device, sensor, electrode, etc.) to a specific location within a tissue mass (e.g., an organ, tumor, other mass of body tissue, etc.) that is located a spaced distance from an open or fluid-filled space, body cavity or body lumen. | 2010-02-25 |
20100047211 | METHOD OF GROWTH OF MESENCHYMAL CELLS UNDER NON-ADHERENT CONDITIONS FOR CLINICAL APPLICATIONS - The invention provides methods for expanding mesenchymal stem cells (MSCs) in non-adherent cultures. The methods include the propagation of MSCs in or on non-adherent matrices. The invention further provides administration and the use of cells propagated by the method of the invention for administration and preparation of a therapeutic agent. The invention further provides kits including cells propagated by the methods of the inventions. | 2010-02-25 |
20100047212 | USE OF THE PEDF FACTOR TO INDUCE CELL REGENERATION - Use of the PEDF factor to induce cell regeneration. The present invention refers to the use of the molecule PEDF for the manufacture of medicines to activate processes included in the group of regenerative processes, such as skin regeneration, wound healing, cell therapy for cardiac, neural, or hematopoietic regeneration. It also refers to the manufacture/use of pharmaceutical compounds that contain an efficient quantity of the PEDF factor for stem cell self-renewal. | 2010-02-25 |
20100047213 | CELL COMPOSITION AND METHODS OF MAKING THE SAME - Provided herein are improved methods for the formulation of compositions comprising placental stem cells, and improved compositions and cell formulations produced thereby. | 2010-02-25 |
20100047214 | Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations - Provided herein are osteogenic placental adherent cells (OPACs), methods of using OPACs and OPAC populations, and methods of culturing, proliferating, expanding, or differentiating the OPACs. Further provided herein are methods of using the OPACs to formulate implantable or injectable compositions suitable for administration to a subject. Still further provided herein are provides methods for treating bone defects with OPACs and compositions comprising OPACs. Also provided herein are methods of using OPACs in the treatment and management of multiple myeloma, e.g., reducing the progression of, halting the progression of, or improving, one or more symptoms of multiple myeloma in an individual having multiple myeloma, comprising administering a plurality of OPACs to the individual. | 2010-02-25 |
20100047215 | STEM CELL TARGETING METHODS - The present invention is directed to methods for delivering stem cells to a target tissue in a mammal using glycoconjugate to traffic the stem cells to a desired organ in the mammal. The methods according to the present invention are especially applicable to administering stem cells such as those derived from the bone marrow or from umbilical cord tissue. The methods are also useful for targeting a gene of interest to a tissue in a mammal by introducing a cell containing the gene of interest and administering a glycoconjugate to the mammal. | 2010-02-25 |